GammaPod - Treatment Planning System-a component of the GammaPod Irradiation System. Ref: XMSGP030A09.07-0.01 Intended for use in the noninvasive stereotactic delivery of a radiation dose to a partial volume of the breast in conjunction with breast conserving treatment.
Published January 24, 2024 · Recall initiated: November 30, 2023
Summary
FDA records medical device Class II recall Z-0750-2024, published January 24, 2024 and initiated November 30, 2023. Recalling firm: Xcision Medical Systems, LLC; Status: Ongoing; Reported quantity: 4 units; Lot: 00850002615029(11)230321(21)TPS0018 (Distributed in the US) 00850002615029(11)230629(21)TPS0013 (Distributed in the US) 00850002615005(11)21H24(21)TPS0016 (Distributed in the US) 00850002615029(11)210629(21 )TPS0014 (Italy). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Wrong structures imported into the GammaPod Treatment Planning System.-system allowed an RTSS generated from a previous CT scan to be selected
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Xcision Medical Systems, LLC
- Distributor
- Worldwide - US Nationwide distribution in the states of MD, PA, TX and the country of Italy.
- Lot
- 00850002615029(11)230321(21)TPS0018 (Distributed in the US) 00850002615029(11)230629(21)TPS0013 (Distributed in the US) 00850002615005(11)21H24(21)TPS0016 (Distributed in the US) 00850002615029(11)210629(21 )TPS0014 (Italy)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDALink Patella Glide Resection Guide- For the implantation of the Endo-Model Knee System as part of a total kneeJanuary 24, 2024
- FDACalibration Serum Level 3. CAL 3, REF CAL2351. Human Assayed Multi-Sera Level 2 (HN1530) Human AssayedJanuary 24, 2024
- FDASOLTIVE SuperPulsed Laser Fibers Model Numbers TFL-FBX150S, TFL-FBX200S, TFL-FBX365S, TFL-FBX550S,January 24, 2024
- FDACalibration Serum Level 3 CAL2351January 24, 2024
- FDA48IN (121.9CM) INJ LINE ROTATING ADAPT (900psi), List Number MX694RJanuary 24, 2024
- FDAGammaPod Stereotactic Radiotherapy System Model A, REF XMSGP030A00-0.02 Product Usage: GammaPod is aJuly 31, 2019
Questions about this recall
Was GammaPod - Treatment Planning System-a component of the GammaPod Irradiation System. Ref: XMSGP030A09.07-0.01 Intended for use in the noninvasive stereotactic delivery of a radiation dose to a partial volume of the breast in conjunction with breast conserving treatment. recalled?
Yes. FDA published recall Z-0750-2024 on January 24, 2024. Reported hazard: Wrong structures imported into the GammaPod Treatment Planning System.-system allowed an RTSS generated from a previous CT scan to be selected
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail